News Summary

Researchers at Mass General Brigham have developed an innovative AI tool named FaceAge, designed to estimate an individual’s biological age and predict survival outcomes, particularly in cancer patients. This deep learning algorithm analyzes facial photos to provide insights into a person’s health status, which could significantly influence treatment decisions in cancer care and other chronic diseases. Initial research has shown that FaceAge can offer more accurate health assessments by evaluating features such as skin folds and temple hollowing, offering a potentially vital diagnostic tool. While primarily trained on white faces, FaceAge is expected to improve its adaptability and accuracy across diverse populations.